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Abstract 
In the scope of the current revision process of the diagnostic manuals Diagnostic and Statistical 
Manual of Mental Disorders (DSM) and International Statistical Classification of Diseases and 
Other Health Problems (ICD), an international trans depathologisation movement has emerged 
that demands, among other claims, the removal of a diagnostic classification of gender transition 
processes as a mental disorder. The call for submissions launched by the American Psychiatric 
Association (APA) and World Health Organisation (WHO) seems to provide the opportunity for 
a participation of civil society in the DSM and ICD revision processes. These developments open 
up a number of questions for us that will be discussed in this article. We conducted a meta-narrative 
review to explore the trans depathologisation movement’s contribution to the DSM and ICD 
revision process, uncover evidence of a ‘democratised turn’ in the process, and any 
depathologisation proposals implemented in trans healthcare practices, human rights frameworks 
and legal gender recognition processes. We argue that the trans depathologisation movement have 
had little impact on medical practices in trans health care. However, there is some movement in 
local health services towards an informed consent model for limited healthcare interventions. 
Within some European and South / Central American legal frameworks, the depathologisation 
movement’s demands to free legal gender recognition from medical interventions and 
examinations have, in different degrees, been incorporated into legal recommendations and 




The revision processes of the Diagnostic and Statistical Manual of Mental Disorders Volume IV-
TR (DSM-IV-TR) and the International Statistical Classification of Diseases and Related Health 
Problems Volume 10 (ICD-10) generated a broad public debate regarding trans-related diagnostic 
categories between academics, clinicians, and activists. The DSM is a diagnostic manual of mental 
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disorders published and updated periodically by the American Psychiatric Association (APA). In 
spite of being developed for the US context, the DSM is known to be applied in a range of countries 
worldwide. Developed by the World Health Organization (WHO) and approved by the World 
Health Assembly, the ICD is an international diagnostic classification system applied worldwide 
for diagnostic and statistical purposes, as well as for regulating reimbursements. It includes both 
‘mental disorders’ and physiological diseases alongside providing numerous codes related to other 
health care procedures for registering them on clinical records. Gender transition processes have 
been included as mental disorders in the ICD since 1975 and in the DSM since 1980. In many 
countries, the connection between medicine and civil status has historically been mandated in the 
process of legal gender recognition for trans people, by means of requiring a trans-specific 
diagnosis and other medical requirements (Monro and van der Ros, Monro, Takács & Kuhar in 
this issue). 
Over the last few years, a trans depathologisation movement has emerged with active 
participation of international and regional trans activism networks, groups and allies. (Suess 
Schwend, 2016). Trans depathologisation activism demands the de(psycho)pathologisation and 
removal of gender transitions as a mental disorder from both the DSM and ICD. However, the 
demand for depathologisation has raised concerns regarding state-funded access to healthcare, 
both from within the trans community and from health professionals. Therefore, the trans 
depathologisation movement is petitioning to attain state-funded transitioning healthcare within a 
human rights framework. Another request is a change in the trans healthcare model, from the 
current psychiatric assessment model to an informed consent approach. A further demand is the 
freeing of legal gender recognition from both medical interventions and diagnostic requirements. 
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The depathologisation of gender diversity in childhood is also an important demand from the 
movement.  
The depathologisation perspective draws on a human rights framework established in the 
Yogyakarta Principles, which are based on the application of international human rights law in 
relation to sexual orientation and gender identity and were developed in 2006 by an international 
group of experts and presented in 2007 in the UN Human Rights Council (O’Flaherty, 2015). The 
rights to human dignity, self-determination, bodily integrity and protection from medical abuse 
has achieved significant importance in the demands for the depathologisation movement and in 
the process of challenging the power that medical professionals hold in the distribution of 
citizenship rights (Suess Schwend, 2016).  
The APA and WHO, in the case of the DSM and ICD respectively, said that they would 
include contributions not traditionally considered during the revision processes. These gestures of 
including research and opinions from medical stakeholders, members of trans communities, and 
political advocacy groups, seems to be a novel method of creating diagnoses for trans people 
(Davy, 2015b; Platero, 2011; Suess Schwend, 2016). Internal workgroups from the APA and WHO 
were tasked with developing diagnoses that reflect trans people’s medical, economic and social 
lives. The APA working groups were established in 2008 and operated for 6 years (APA, 2013), 
while the WHO working groups were active from 2007 for 9 years (WHO, 2017a).  The 
workgroups collected and exploited the evidence that they gathered in different ways. These 
developments opened up a number of questions for us:  
1. What were the contributions and responses to the DSM and ICD revision process from 
the trans depathologisation movement?  
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2. If and to what degree has the process of creating trans-related diagnoses in the DSM and 
ICD taken a democratised turn?  
3. To what extent have depathologisation movement’s proposals been incorporated into 
standards of care and trans healthcare policies? 
 4. In what ways have human rights frameworks and legal gender recognition been 
impacted by depathologisation discourses?  
 
Methodological approach 
We conducted a meta-narrative review (Gough et al., 2012), which explored the depathologisation 
debate and potential impact on medico-legal and policy contexts for trans people. We synthesised 
the findings and conclusions from existing policy documents, commentaries and declarations from 
academic, medical, legal and activist bodies to address the research questions (above). Because 
the conclusions and commentaries vary within different research paradigms, have political 
leanings and function within structural parameters ontologically, epistemologically, theoretically 
and ideologically (Gough et al., 2012), a meta-narrative review was chosen to understand the ways 
in which the debate about creating new trans diagnoses and medicolegal policies was understood 
and positionally argued from. The first analytical stage developed a disciplinary framework, upon 
which the authors agreed. The literature was assigned a ‘disciplinary label’ from the following: 
trans depathologisation movement and allies, medical responses, international and regional human 
rights discourses and domestic legal responses. From this, we developed an analysis that mapped, 
then reviewed the claims and declarations made by the trans depathologisation movement and their 
academic and medical allies and sought to analyse the inclusion of the depathologisation 
perspective in medical and health policy documents, and legal statutes. We did this, by drawing 
out if and where trans depathologisation contributions and responses were included in the 
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published DSM-5 and in the ICD-11 Beta Draft, and in declarations about health service provision, 
international and regional human rights documents and legal statutes in a number of countries. The 
importance of garnering an understanding of the impact was to highlight the trans 
depathologisation movement’s social and paradigmatic influence within the DSM and ICD 
revision processes, the international and regional human rights framework and medico-legal 
legislation in a number of countries worldwide. 
We reviewed 157 documents published between 2009 and 2016 by local, regional and 
international activist groups and networks, among them 74 issued by regional and international 
activist groups and networks.  Furthermore, we reviewed the following documents issued between 
2009 and 2016, a selection of 150 concluding observations from UN treaty bodies, 12 resolutions 
from the Council of Europe Parliamentary Assembly, one issue paper from the Commissioner for 
Human Rights and one recommendation from the Committee of Ministers. Further, we reviewed 
trans people’s access to legal gender recognition in 17 countries by identifying national laws that 
either were passed or amended between 2009 and 2016 that have clear conditions for legal gender 
recognition, and that do not precondition a trans-related diagnosis, hormone therapy and/or 
surgical interventions. Of these, we chose a sample of 10 national laws. 
We start our analysis with a short contextualisation of the appearance of diagnoses in the 
DSM and ICD and the power that psychiatrists hold in relation to medical and healthcare for trans 
people. This provides the context in which the trans depathologisation movement has arisen. We 
will then look at some of the transformations in policy towards patient-centred medicine, which 
the movement is drawing on to challenge the pathologisation of trans people. We analyse the 
degree to which the demands of the trans depathologisation movement were considered in the 
DSM-5, in the ICD-11 Beta Draft, in international and regional human rights documents and in 
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the legal statutes considered in this article. As a caveat, we are not testing the ways that the 
demands and declarations are utilised by health practitioners or how they impact those people the 
DSM and ICD diagnostic classifications and legal statues (will) affect, although these would be 
worthwhile future projects. We are providing descriptions of claims in the debate to demonstrate 
the use of trans depathologisation demands and declarations in institutional documents. 
Particularly we provide an analysis of the published discourses emerging during the revision of 
trans-related categories in the DSM and ICD from academic and activist perspectives. We will 
also explore the participation in the revision process. Furthermore, we will illustrate the level of 
trans depathologisation frameworks introduced in the standards of care and trans healthcare 
practices. To end the article we will describe the human rights discourse underpinning legal gender 
recognition and examine the role that trans-related diagnoses play in law in a number of countries.  
 
Politics of psychiatric diagnoses   
Prior to the 1960s, some early clinicians from private, non-academic gender clinics provided trans 
people transitioning surgery on demand and justified it on grounds of correcting what they 
considered (intersex) ‘anomalies’ (Stone, 1991). In the 1960s, clinicians began to refuse surgery 
on demand, because of the professional risks of performing experimental medicine. Clinicians 
started to develop criteria for approval onto gender identity programs (e.g. Benjamin, 1966). The 
diagnosis of transsexualism as a psychiatric ‘disorder’ appeared in the ICD-9 in 1975 (WHO, 
1975) and in the DSM-III in 1980 (APA, 1980). There have been a number of diagnostic changes 
relating to trans people’s gender identity issues since. Any changes in trans diagnoses have been 
developed by workgroups consisting of psychiatrists and sexologists appointed by the APA and 
WHO. Clinicians and researchers have previously said that the diagnostic changes have occurred 
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because of advances in both science and culture (Levine and Solomon, 2008). While we do not 
have the space to consider the nuances of what psychiatric diagnoses endorse for trans people, we 
observe that, with the exception of a few recent changes in some countries, a psychiatric diagnosis 
is a prerequisite for major citizenship and healthcare rights for many trans people. 
Jutel (2011) argues that diagnosis changes the practice of medicine from a purely 
biomedical process to a medico-social practice with intersecting social, political, technological, 
cultural and economic forces. According to Frank (2016), however, the diagnosis must not support 
any secondary gains, which is not always the case with psychiatric approaches to trans people. 
Secondary gains for trans people are varied, including providing referrals to surgeons for surgery, 
or providing evidence for amendments to the civil status of a patient’s gender. In this sense, 
psychiatric diagnostics are personal-political-economic matters that masquerade as medical 
measures (Szasz, 2009). 
Some recent research about psychiatric practices addresses the justice and equality issues 
inherent in some psychiatric practices (Kallert, 2008; Lidz et al., 2000). Psychiatry relies on 
‘talking’ and pharmacological strategies that coerces people into acting in line with the attendant 
psychiatrist’s standards of behaviour, while advocating what is ‘normal’ and ‘abnormal’ conduct. 
Trans depathologisation discourses, together with anti-psychiatric perspectives, have started to 
discuss how psychiatric diagnosis can be coercive, even in the face of widespread health policies 
shifting towards patient-centred medicine. 
 
Patient-centred health policy 
Major transformations in policy towards patient-centred medicine1 from the late 1960s (Balint, 
1969), and changes in approaches from physicians and psychiatrists has resulted in a debate about 
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the importance of people being at the forefront of their own healthcare. Health policy in Europe 
over the last ten years has acknowledged research demonstrating the benefits of shared decision-
making, and promotion of individual and collective patient rights as dominant values and goals 
(Newdick and Derrett, 2006). Some research shows great gains in health outcomes and the benefits 
of patient-centred healthcare provision (Mead and Bower, 2000; Saha et al., 2008). However, there 
has been some research that shows attempts to negotiate shared decision making is sometimes 
fraught with difficulties from both patients’ (Frosch et al., 2012) and practitioners’ perspectives 
(Caldon et al., 2010). 
The introduction of an informed consent model for hormone therapy in the US has been 
welcomed by many trans people and health service providers (Deutsch, 2012). Informed consent 
healthcare for trans people has not been widespread, and rarely extends to surgical interventions, 
if so desired. As such, the ways that trans people are treated, within healthcare policies and clinics, 
continue to be sites of activist and lay negotiations and much political, cultural, legal and scientific 
wrangling (Davy, 2015b; Drescher, 2013; Drescher et al., 2012; Platero, 2011, Van der Ros, 2013). 
 
Trans depathologisation movement 
Critical challenges by trans people about their healthcare have often evolved through health social 
movements (HSM). HSMs engage in generating research of their own, democratising the 
production of scientific knowledge. This research variably helps to shape health policies and 
influence treatments and protocols (Brown and Zavestoski, 2004). For instance, the entwined trans 
diagnoses, governance and citizenship rights mechanisms in social policy and legal statutes have 
received some international scrutiny (Cabral and Viturro, 2006; Spade, 2003; Stone, 1991; Suess 
Schwend, 2016; Whittle, 2002; Wilchins, 1997). Trans depathologisation discourses have emerged 
9 
 
from Africa (Gunguluza, 2012), Asia (Winter, 2009; Winter et al., 2009), Latin America (Adrián, 
2013; Cabral, 2010, 2014), North America (Winters, 2006, 2008, 2013) and Europe (Davy, 2011; 
Meyer-Bahlburg, 2010; Richardson and Monro, 2012; Suess Schwend, 2016). 
Contemporary trans HSMs are divided in the ways that they should tackle policy and access 
to healthcare. The analysis of activist campaigns over the last few years, however, shows an 
increasing consensus about the removal of psychiatric diagnoses while preserving access to 
healthcare (Suess Schwend, 2016). Nonetheless, according to Meyer-Bahlburg (2010), Franklin 
Romeo of the Sylvia Rivera Law Project in New York has suggested that a DSM diagnosis is 
crucial in court proceedings concerning access to insurance facilitated healthcare in the US where 
public health care is scarce. In Romeo’s view (Meyer-Bahlburg, 2010), the removal of trans 
diagnoses would be disastrous for US trans people. Nevertheless, the Argentinian Gender Identity 
Law, enacted in 2012 (see below) provides the right to legal gender recognition without medical 
requirements while establishing the right to state-funded trans healthcare within an informed 
consent model. The Argentinian law now sets a reference point for the development of other 
national legal frameworks and health policies that many trans activists cite as encompassing their 
rights for human dignity, bodily integrity and self-determination. 
International trans depathologisation activism has continued to emerge, achieving a broad 
dissemination of their praxes in different world regions. Since 2009, STP, International Campaign 
Stop Trans Pathologization launches each year a Call to Action for the International Day of Action 
for Trans Depathologization. On this day and throughout the month of October, activist groups, 
organisations and networks from different world regions organise activities advocating for trans 
depathologisation. In October 2016, more than 120 activities took place in 47 cities worldwide. 
Furthermore, by June 2017 STP received endorsements from 412 activist groups and networks, 
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public institutions and political organisations in Africa, Asia, Europe (including Western and 
Eastern Europe), Latin America, North America and Oceania. The main demands of STP are the 
removal of the mental disorder classification of gender transitioning processes from the DSM and 
ICD, the right to the provision of state-funded trans healthcare, changes to existing trans healthcare 
models, legal gender recognition without medical requirements, depathologisation of gender 
diversity in childhood, and protection against discrimination and transphobia. In order to facilitate 
state-funded trans healthcare provision, STP proposes: 1. The elaboration of a human rights-based 
framework for trans healthcare, 2. The introduction of a non-pathologising code in the ICD, as a 
health process not based on disorder or disease, and 3. The elaboration of context-specific 
strategies (Suess Schwend, 2016).2 
International activist networks have published declarations supporting the demand for trans 
depsychopathologisation3 and many local activist groups have launched similar declarations 
(Suess Schwend, 2016). Trans academics, many of whom are activists, have recently contributed 
to the debate about trans depathologisation (Cabral, 2010, 2014; Davy, 2015b; Gunguluza, 2012; 
Missé and Coll-Planas, 2010a, 2010b; Platero, 2014; Suess, 2010; Suess Schwend, 2016; Suess et 
al., 2014; Thomas et al., 2013; Winter, 2014, 2015; Winter et al., 2009; Winters, 2008, 2013, 
2014). This debate has built on trans activism that emerged a few decades ago (e.g. Burns, 2005; 
Spade, 2003; Stone, 1991; Stryker, 1994; Wilchins, 1997; Wilson, 1997, 2010; Winters, 2006; for 
activist actions see Suess Schwend, 2016). Apart from publishing declarations, activist groups and 
networks participated in the Call for Proposals launched by the APA by sending reviews of the 
trans-related diagnostic categories published on the DSM-5 Draft website, including proposals for 
their reform or removal. After the publication of the DSM-5 (APA, 2013), STP criticised the 
continued classifications Gender Dysphoria in Adolescents and Adults, Gender Dysphoria in 
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Children and Transvestic Disorder (APA, 2013), demanding the complete removal of trans-related 
categories from DSM-5. 
In 2011, the WHO called for proposals on the revision process of trans-related categories 
in the ICD (Drescher et al., 2012). Among the received proposals, listed in Drescher, et al. (2012) 
was a report developed by Global Action for Trans Equality (GATE), which summarises the results 
of an International Expert Meeting that congregated in The Hague in November 2011. In the 
meeting, a proposal for non-pathologising trans-related codes in ICD-11 were elaborated on, in 
order to facilitate access to state-funded trans healthcare. In 2013, GATE organised a second 
meeting in Buenos Aires, and focused on developing arguments for the removal of the diagnostic 
classification of gender diversity in childhood from the ICD. Furthermore, the meeting produced 
an alternative proposal for the ICD-11 based on codes listed in ICD-10 Chapter XXI, Factors 
influencing health status and contact with health services, with the aim of facilitating access to 
psychosocial support for those gender diverse children and their families who require it.  
Over the last two years, several international and regional trans activist networks have 
published statements demanding the removal of a diagnostic classification of gender diversity in 
childhood. By June 2017, 231 health professionals and researchers from different world regions 
signed a statement supporting this demand (Winter et al., 2016). Trans authors and allies have 
questioned the maintenance of diagnostic categories for pre-adolescent children (Adams, 2014; 
Cabral, et al. 2016; Suess Schwend, 2016, 2017; Winter, 2014, 2015; Winter, Diamond, et al. 
2016; Winter, Ehrensaft, et al. 2016; Winter, Riley, et al. 2016; Winters, 2013, 2014). This 
questioning is based on earlier critiques of the diagnostic classification of gender diversity in 
childhood (Bartlett et al., 2000; Langer and Martin, 2004). Furthermore, several activist groups 
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and networks have demanded the publication of the WHO workgroup proposal so that trans 
activists can make a formal critique of it.  
After the proposal of the Working Group on the Classification of Sexual Disorders and 
Sexual Health being published in the ICD-11 Beta Draft in August 2014 (WHO, 2017b), several 
activist networks launched press releases, praising the removal of trans related categories from the 
chapter Mental and Behavioural Disorders. The networks also agreed with the inclusion of a trans-
specific category for adolescents and adults in the proposed chapter Conditions related to sexual 
health (WHO, 2017b), while criticising the continued classification of gender diversity in 
childhood and the concept “gender incongruence.”   
Trans depathologisation activism has also demanded a change in healthcare provision by 
suggesting replacing any system using psychiatric assessments as a precursor to the provision of 
hormone treatments and trans-related surgeries with an informed consent approach. The informed 
consent model focuses on information and counselling and recognises trans people’s right to bodily 
autonomy and informed decision making (Suess Schwend, 2016). During the revision process of 
the 6th version of the Standards of Care (SOC-6), published by the Harry Benjamin International 
Gender Dysphoria Association (HBIGDA) in 2001 (now World Professional Association for 
Transgender Health (WPATH)), activist groups and networks worldwide provided alternative 
proposals, based on a depathologisation framework, taking into account some culturally specific 
aspects of trans people’s lives. After the publication of SOC-7 in 2012 (WPATH, 2012), several 
activist networks published their reviews of the new edition. The networks acknowledged that 
there had been some improvements: the conceptualisation of gender transitions as non-
pathological, the challenging of non-discriminatory language, the inclusion of a broad diversity of 
gender expressions, transitioning trajectories and gender identities, the need for flexibility in trans 
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healthcare pathways, the explicit condemnation of reparative therapies, and the recognition of the 
cultural diversity of trans people. Simultaneously, the activist networks criticised the use of a 
pathologising diagnostic framework, the continuation of an assessment model, including the 
requirement of “12 continuous months of living in a gender role that is congruent with [trans 
people’s] gender identity” (WPATH, 2012: 60, 106), and the pathologising terminology used in 
the chapter on intersex.  
In relation to legal gender recognition, the trans depathologisation movement demands that 
future gender identity laws be without medical requirements and restrictions related to the civil 
status, such as having to be divorced if married, age or nationality. Furthermore, they insist that 
governments remove such requirements from existing gender identity laws (Suess Schwend, 
2016). Viewed as forms of medical abuse and coercion by activists, the compulsory legal 
requirements of diagnosis, hormone treatment, sterilisation, genital surgery or divorce constitute 
human rights violations and are an obstruction to the right to bodily integrity and right to a family 
life. Moreover, medical requirements are contrary to the rights established in the Universal 
Declaration of Human Rights, and Yogyakarta Principles. Trans depathologisation activist groups 
and networks have celebrated the Argentinian Gender Identity Law, and legal gender recognition 
advancements, such as the approval of gender identity laws without medical requirements in 
Denmark, Malta, Colombia, México D.F., Ireland and Norway, the removal of the sterilisation 
requirement in Sweden, as well as other law proposals, such as in Chile. Simultaneously, activists 
continue to denounce any legal criminalisation and persecution, social and labour exclusion and 
transphobic violence. This leads us to a discussion about the level of impact that depathologisation 




Depathologisation as a human rights issue 
The rights of trans people regarding legal gender recognition and access to trans health care have 
gathered momentum under the case law of the European Court of Human Rights (ECtHR). The 
court’s interpretation of article 8 of the European Convention on Human Rights (ECHR) ensures 
the right to respect for a private life (Christine Goodwin v. the United Kingdom; van Kück v. 
Germany). Pathologisation of transsexuality has had limited discussion against the backdrop of 
international human rights law. Yet, depathologisation can be addressed under article 8 detailing 
the right to a private life in the ECHR and in article 17 of the International Covenant on Civil and 
Political Rights. Gender identity is one of the most intimate aspects of a person’s life, which falls 
within the ambit of article 8 (Goodwin). Article 8 protects the right to personal development, to 
establish details of one’s identity, and the physical and psychological integrity of a person 
(Goodwin; van Kück). To be labelled as mentally ill encroaches on the integrity of people and 
cannot be justified under article 8 (2). Depathologisation falls also under the right to health (article 
12) and non-discrimination (article 2(2)) under the International Covenant on Economic, Social 
and Cultural Rights (ICESCR), particularly because of the stigma attached to pathologisation and 
how being labelled as mentally ill affects the health of trans people (Theilen, 2014). The 
pathologising of trans people and not cis people cannot be justified, according to Theilen (2014), 
and amounts to discrimination. An increased body of soft law supports these views, such as the 
Yogyakarta Principles.  
 The Yogyakarta Principles are not legally binding, but the Principles have attained wide 
international recognition as “an important tool in identifying the obligations of states to respect, 
protect and fulfil the human rights of all persons, regardless of their sexual orientation or gender 
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identity” (Hammarberg cited in O'Flaherty, 2015: 291). Of interest to this article, is Principle 18, 
which declares: 
Notwithstanding any classifications to the contrary, a person’s sexual orientation and 
gender identity are not, in and of themselves, medical conditions and are not to be treated, 
cured or suppressed. 
When addressing medical requirements for legal gender recognition, human rights 
mechanisms are increasingly pursuing this view, as well as urging states to abolish trans-related 
diagnosis as a precondition for legal gender recognition and to ensure access to trans-specific 
healthcare without requiring a mental illness in line with the demands of the depathologisation 
movement. For example, in its 2011 Concluding Observation to Germany, the Committee on 
Economic, Social and Cultural Rights stated: 
The Committee notes with concern that transsexual and inter-sexed persons are often 
 assimilated to persons with mental illness and that the state party’s policies, legislative or 
 otherwise, have led to discrimination against these persons as well as to violations of 
 their sexual and reproductive health rights (arts. 12, 2.2).  
Yet, in the 150 concluding observations reviewed, UN treaty bodies only address medical 
requirements for legal gender recognition and/or access to trans-specific healthcare in four of the 
concluding observations. Sexual orientation and/or gender identity are mentioned in 63 concluding 
observations, and particularly in relation to protection against discrimination.  
In 2009, in the issue paper Human Rights and Gender Identity, the former Commissioner 
for Human Rights Thomas Hammarberg (2009: 25) emphasised that “[f]rom a human rights and 
health care perspective no mental disorder needs to be diagnosed in order to give access to 
treatment for a condition in need of medical care.” Further, in five out of 12 Council of Europe 
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Parliamentary Assembly (PACE) resolutions that include trans people or gender identity, explicit 
reference to medical requirements for legal gender recognition and access to trans-specific 
healthcare was made. In 2015, for example, PACE expressed its concern about the human rights 
violations trans people face when seeking legal gender recognition that requires inter alia 
sterilisation and a diagnosis of mental illness. PACE (2015) and the Council of Europe Committee 
of Ministers (2010) call on European member states to abolish sterilisation, compulsory medical 
treatments, and a mental health diagnosis to gain legal gender recognition, while ensuring access 
to and reimbursement by public health insurance schemes for gender reassignment procedures. 
While human rights mechanisms have primarily been focusing on sterilisation, depathologisation 
and access to state-funded healthcare are increasingly gaining attention as a human rights issue.   
 
National law reforms on legal gender recognition 
The demands of the depathologisation movement to 1) free legal gender recognition from medical 
interventions, such as genital surgery or sterilisation, 2) to detach legal gender recognition from 
any medical requirements, including surgical interventions, medical examinations and diagnoses, 
and 3) to ensure state-funded transitioning healthcare, will facilitate a complete distinction between 
medicine and legal gender recognition. Recent national legal gender recognition laws have 
responded to these demands in varying ways. 
Before the establishment of an international depathologisation movement, local groups 
worked actively in freeing legal gender recognition from medical requirements. As a result, in the 
UK (2004) and Spain (2007) laws they did not require surgical interventions. However, the British 
Gender Recognition Act requires a diagnosis of either gender dysphoria or evidence of surgical 
interventions, whereas the Spanish gender identity law requires gender dysphoria and two years of 
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medical treatment, usually hormone treatment. From 2009 to 2016, national legislative bodies in 
different countries enacted laws that freed legal gender recognition from more medical 
requirements.  
The depathologisation movement demands that legal gender recognition shall be detached 
from medical interventions. The 2011 Portuguese gender identity law requires the applicant to be 
diagnosed with gender identity disorder and be over 18 years (article 2). A diagnosis must appear 
in a report prepared by a multidisciplinary clinical sexology team (article 3 (1) b). The registrar 
shall decide on the request for change of legal gender within eight days (article 4). Contrary to the 
Swedish act (see below), the act explicitly requires the diagnosis of gender dysphoria.  
In 2013, the 1972 Swedish Act legally recognising trans people was amended and the 
infertility/sterilisation requirement repealed. Contrary to the acts mentioned above, the 
requirement of a diagnosis or medical examination follows from an interpretation of the wording 
of the law, which shows similarities with the definition of the diagnosis of gender dysphoria (SOU 
2014: 91 para 7.9.1) and from medical recommendations. Common for these laws is that they 
comply with the demand of freeing legal gender recognition from requirements of sterilisation or 
infertility. However, legal gender recognition requires medical examinations or a diagnosis.  
Contrary to the laws mentioned above, the Argentine Gender Identity Act (2012), the 
Danish Act on the Civil Registration System (as amended 2014), the Maltese Gender Identity, 
Gender Expression, and Sex Characteristics Act (2015), the Columbian Gender Recognition Act 
(2015), the Civil Code of Mexico City (as amended 2015), the Irish Gender Recognition Act 
(2015), the French Gender Identity Act (2016), and the Norwegian Act on Change of Legal Gender 
(2016) all detach legal gender recognition from medical interventions for people above 18 years. 
In 2012, the Argentine Senate enacted the Law 26.743, including a regulation for the right to 
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gender identity and comprehensive state-funded healthcare for trans people. The act introduced an 
unprecedented law for trans people based on human rights principles. No medical diagnosis or 
treatment is required for a change of legal gender and it allows children to consent to change their 
legal gender when supported by their legal representatives.  
Similarly, the Maltese Gender Identity, Gender Expression, and Sex Characteristics Act 
adopted 2015, complies with most of the demands of the depathologisation movement. The Act 
explicitly ensures the right of all Maltese citizens to recognition of their gender identity (Section 
3), and a correction of the recorded gender without any requirements of diagnosis or medical 
treatment (Section 4). Any change of a recorded gender is self-declarative. Additionally, the act 
enshrines the bodily integrity and physical autonomy of minors when outlawing sex assignment 
treatment and/or surgical intervention on the sex characteristics of a minor (Section 14 (1)). By 
way of an amendment to the act in 2016, pathologisation of any form of gender identity or gender 
expression as classified under the ICD or any other similar internationally recognised classification 
is invalid in Malta (Section 15 (2)). Further, the Affirmation of Sexual Orientation, Gender Identity 
and Gender Expression Act enacted in 2016, prohibits pathologisation of any gender identity or 
gender expression. However, trans-specific state-funded healthcare is not ensured under the law.  
The French act frees legal gender recognition from medical interventions and 
examinations, but requires a court procedure rather than self-declaration of gender. The Norwegian 
act provides change of legal gender based on self-declaration from the age of 16. For children 
between the age of 6 and 16, change of legal gender requires, as a main rule, consent from those 
with the parental responsibility, but no diagnosis or medical examination is required. However, for 
children below 6 years, the act introduces a diagnostic requirement where healthcare professionals 
must document that they have “a congenital somatic sex development uncertainty” for the 
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correction of legal gender to be granted. Further, the act does not ensure a right to state-funded 
trans-specific healthcare (Sections 2, 4 and 5; Monro and van der Ros, in this journal; Sørlie, 2016). 
Thus, the Act does only partially meet the demands of the depathologisation movement. Under the 
Irish Act, people over the age of 18 years can self-declare their gender (Section 9). For children 
who have attained the age of 16 years but not 18 years, however, a certification from two medical 
practitioners, parental consent and court order are required (Section 12). The act does not allow 
children below the age of 16 years to obtain legal gender recognition. Neither the Irish act nor the 
Norwegian act does cut off the ties to the medical profession completely.  
A lack of available trans-specific healthcare may negatively affect the health of trans 
people and their right to respect for their private life sanctioned under Article 8 of the ECHR and 
the right to health under article 12 of the ICESCR, as demonstrated above. Yet, of the gender 
recognition acts enacted or amended between 2009 and 2016, it is only the Argentine gender 
recognition law that ensures access to trans-specific healthcare. Article 11 of the Act approves a 
self-determined right to “total and partial surgical interventions and/or comprehensive hormonal 
treatment to adjust their bodies” (cited in Dunne et al., 2015: 580). 
The developments in some national legislation law reforms follow the Argentine example 
by casting aside medical interventions, medical examinations and trans-related diagnoses. Yet, in 
most countries, there is still a need for much improvement of national gender recognition laws to 
meet the demands of the depathologisation movement. Particularly, this concerns those countries 
in which gender recognition laws require sterilisation and genital surgery, but also those countries 
in which diagnosis is maintained in, for example, England, Spain and Portugal alongside more 
recent legislation, such as the Irish, French and Norwegian gender recognition acts. According to 
TGEU and Balzer (2016a, 2016b), in 29 of 62 mapped countries / territories worldwide in which 
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legal change of gender is possible, sterilisation and/or genital surgery are still required for a change 
of the gender marker, and in 54 of the 62 countries / territories, a diagnosis requirement is 
maintained.  
 
Summary and conclusion 
The first question we raised at the start of this article was about the contribution of the 
depathologisation movement to the revision process of trans-related diagnoses in DSM and ICD. 
Some trans people have concerns about removing the diagnostic classification of gender transition 
processes, based on the fear of losing access to state-funded trans healthcare (García Becerra and 
Missé, 2010; Missé and Coll-Planas, 2010b). Trans depathologisation activism has responded to 
this concern by developing arguments based on a human rights framework (Suess Schwend, 2016).  
During the DSM and ICD revision processes, trans depathologisation groups and networks 
demanded a higher level of participation, however, we observed in relation to our second question 
about the democratisation of diagnosis that the opportunities for trans activists’ and networks’ to 
participate were curtailed within the consultation process. Trans authors and allies have been able 
to contribute critiques on the participation process and the proposed and final content, but have no 
guarantees that their critiques were heard or taken into consideration. Stakeholders were also 
unable to take part in the final decision making processes. Activists have also illustrated that there 
are tensions between challenging the diagnostic framework while participating in its reform, and 
managing the fear of reduced activist impact in the negotiation process (Fernández, 2010; Missé, 
2012). As such, a “democratisation of diagnosing” (Davy, 2015a) seems to be still incipient. 
Trans depathologisation activism criticises the maintenance of an assessment model in the 
most recent edition of the Standards of Care SOC-7 (WPATH, 2012), as well as in trans healthcare 
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practice. Activists are proposing the use of an informed consent approach and convincingly 
highlight its relation to patient-centred healthcare and shared decision-making models, which are 
increasingly being applied in wider healthcare settings (Balint, 1969; Mead and Bower, 2000; 
Newdick and Derrett, 2006; Saha et al., 2008). However, these proposals have had little impact on 
medical practices in trans health care. Nonetheless, there is some movement in health services. For 
instance, there are a few trans health care centres in the US that use an informed consent model 
for access to hormone therapy (Callen Lorde Community Health Center, 2014; Radix, 2011; Tom 
Waddell Health Center, 2011). Also, there is a guarantee in the Argentinian Gender Identity Law 
of an informed consent approach for state-funded trans health care (Congreso Argentino, 2012), 
and there are trans health care services based on informed decision making in the public health 
care system of Andalusia, Spain (Junta de Andalucía, 2017a, 2017b).  
In relation to the ways that human rights frameworks and legal gender recognition has been 
impacted by depathologisation discourses, we have demonstrated that the human rights principles 
of human dignity, bodily integrity, self-determination and protection from medical abuse are 
significant in trans depathologisation activism as reference points, and as part of an argumentation 
strategy. At the same time, recent strategic documents published by European political and legal 
institutions have recommended the removal of the diagnostic classification of gender transition 
processes in the ICD, integrating the demand of depathologisation in their agenda (Suess Schwend, 
2016).  
We note that in many countries worldwide trans people still lack opportunities for legal 
gender recognition. In achieving legal recognition of their gender identity, some trans people’s 
human rights are violated through processes of coercive diagnosing and sterilisation. In countries 
like Spain, the United Kingdom and Portugal the requirement of a trans-related diagnosis continues 
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to be coupled with legal gender recognition. According to Sharpe (2010), British legislation 
presupposes body modification even though no surgical or hormonal requirements were written 
into law. This is so, Sharpe argues, because trans people must exhibit gender dysphoria, which is 
usually understood as distress about ‘sex’ characteristics. Consequently, legal requirements based 
upon trans-related diagnoses pose a risk of reintroducing surgical and hormonal practices through 
the back door. Moreover, these diagnoses act as gatekeeper to other healthcare services and 
citizenship rights. This then constitutes a coercive relationship by offering something positive – 
healthcare and legal recognition – in exchange for compliance with psychiatry. The Argentinian 
Gender Identity Law, however, is exemplary at guaranteeing trans rights – both legal recognition 
and healthcare access – within a human rights framework, setting a reference point for recent law 
reforms, as well as for the ICD revision process. Trans movement participation should be 
encouraged in the processes of guaranteeing human rights for trans people. 
 
Notes 
1 Recently, the term “person-centred healthcare” or “people-centred healthcare” is given 
preference over “patient-centred” and are considered more inclusive, empowering and focused on 
the person’s and community’s needs (WHO-WPRO, 2016). 
2 A list of activist documents published between 2009 – 2015 can be found in Suess Schwend 
(2016). Declarations published between January 2016 and June 2017 are available on the 
websites of APTN, Asia Pacific Network; GATE, Global Action for Trans Equality; ILGA-
World; Iranti.org; STP, International Campaign Stop Trans Pathologization and TGEU, 
Transgender Europe. 
3 Depsychopathologisation is a demand shared by all activist groups in relation to changes in trans-
related diagnostic categories. Simultaneously, there are different proposals regarding the inclusion 
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of an alternative diagnostic category in ICD that will ensure public coverage of trans healthcare, 
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